3MO Genomic evolution of non-small cell lung cancer during the establishment and propagation of patient-derived xenograft models (2022)
Attributed to:
ImmuneMetTx
funded by
Horizon Europe Guarantee
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.annonc.2022.09.004
Publication URI: http://dx.doi.org/10.1016/j.annonc.2022.09.004
Type: Journal Article/Review
Parent Publication: Annals of Oncology